HCMV US2 co-opts TRC8 to degrade the endoplasmic reticulum-resident protein LMAN2L
Journal of General Virology · 2024
DOI: 10.1099/jgv.0.001980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of General Virology, 2024. Verfasst von Leah M Hunter und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK. Hauptthemen laut MEDLINE: Cytomegalovirus, Endoplasmic Reticulum, Viral Proteins, Viral Envelope Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Department of Health, Medical Research Council.
Abstract (Originalsprache)
The human cytomegalovirus (HCMV) pUS2 glycoprotein exploits the host’s endoplasmic reticulum (ER)-associated degradation (ERAD) pathway to degrade major histocompatibility complex class I (MHC-I) and prevent antigen presentation. Beyond MHC-I, pUS2 has been shown to target a range of cellular proteins for degradation, preventing their cell surface expression. Here we have identified a novel pUS2 target, ER-resident protein lectin mannose binding 2 like (LMAN2L). pUS2 expression was both necessary and sufficient for the downregulation of LMAN2L, which was dependent on the cellular E3 ligase TRC8. Given the hypothesized role of LMAN2L in the trafficking of glycoproteins, we employed proteomic plasma membrane profiling to measure LMAN2L-dependent changes at the cell surface. A known pUS2 target, integrin alpha-6 (ITGA6), was downregulated from the surface of LMAN2L-deficient cells, but not other integrins. Overall, these results suggest a novel strategy of pUS2-mediated protein degradation whereby pUS2 targets LMAN2L to impair trafficking of ITGA6. Given that pUS2 can directly target other integrins, we propose that this single viral protein may exhibit both direct and indirect mechanisms to downregulate key cell surface molecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK.
- Department of Medicine, University of Cambridge, Hills Road, Cambridge, CB2 2QQ, UK.
- Cardiff University School of Medicine, Division of Infection and Immunity, Henry Wellcome Building, Heath Park, Cardiff CF14 4XN, UK.
Förderung
- Wellcome Trust
- Department of Health
- Medical Research Council
- NIHR Cambridge Biomedical Research Centre
Zitieren
APA
Hunter, L. M., Kite, J., Fletcher-Etherington, A., Nightingale, K., Nobre, L., Antrobus, R., Fielding, C. A., Stanton, R. J., & Weekes, M. P. (2024). HCMV US2 co-opts TRC8 to degrade the endoplasmic reticulum-resident protein LMAN2L. Journal of General Virology. https://doi.org/10.1099/jgv.0.001980
Vancouver
Hunter LM, Kite J, Fletcher-Etherington A, Nightingale K, Nobre L, Antrobus R, et al. HCMV US2 co-opts TRC8 to degrade the endoplasmic reticulum-resident protein LMAN2L. Journal of General Virology. 2024. doi:10.1099/jgv.0.001980
BibTeX
@article{Hunter2024,
author = {Hunter, Leah M and Kite, Joanne and Fletcher-Etherington, Alice and Nightingale, Katie and Nobre, Luis and Antrobus, Robin and Fielding, Ceri A and Stanton, Richard J and Weekes, Michael P},
title = {HCMV US2 co-opts TRC8 to degrade the endoplasmic reticulum-resident protein LMAN2L},
journal = {Journal of General Virology},
year = {2024},
doi = {10.1099/jgv.0.001980}
}
EUVIMED